A detailed history of Peak6 Investments LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Peak6 Investments LLC holds 10,000 shares of XFOR stock, worth $3,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$3,400
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$1.03 - $2.02 $10,300 - $20,200
10,000 New
10,000 $10,000
Q4 2022

Feb 10, 2023

SELL
$0.69 - $2.21 $27,599 - $88,400
-40,000 Reduced 66.45%
20,200 $20,000
Q3 2022

Nov 14, 2022

BUY
$0.89 - $1.71 $53,578 - $102,942
60,200 New
60,200 $103,000

Others Institutions Holding XFOR

About X4 Pharmaceuticals, Inc


  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.